Another study found that both anti-CdtB and anti-vinculin biomarkers were elevated in subgroups, of irritable bowel syndrome with constipation (IBS-C) and IBS-D, while only anti-vinculin biomarkers were elevated in irritable bowel syndrome mixed type (IBS-M) subgroups [17]. This evidence concerns the gene VCL and constipation disorder.